DNMT1 and ovarian carcinoma: Regarding the significance of the demethylating effect of hydralazine in the induction of apoptosis, a reduction of DNMT1 protein level and activity has been observed in ovarian cancer cells in response to treatment for one day with hydralazine in a range of doses from 150 to 600 μM [24].